文献速递中毒与环境急症重症综合管理与镇静镇痛心脑血管急症

中毒性酒精中毒危重患者的神经系统并发症:一项多中心人群队列研究

Neurologic Complications in Critically Ill Patients with Toxic Alcohol Poisoning: A Multicenter Population-Based Cohort Study.
PubMed 文献 · Neurocrit Care · 2023-09-11
一句话结论甲醇中毒是ICU收治的最常见中毒性酒精中毒,阴离子间隙增宽和GCS降低独立预测不良神经结局,阴离子间隙≥28者无良好恢复。

该研究为加拿大阿尔伯塔省2007至2019年多中心人群回顾性队列,纳入104例因中毒性酒精中毒入住ICU的危重患者,其中甲醇55例(53%)、乙二醇36例(35%)、异丙醇13例(13%)。神经影像异常在甲醇组为9/24(38%)、乙二醇组为5/20(25%)、异丙醇组为0/10(p=0.07);死亡、持续认知障碍或视力丧失复合终点在甲醇组为13例(24%),乙二醇组1例(3%),异丙醇组0例(p=0.006)。甲醇中毒患者中,阴离子间隙升高和GCS降低是不良结局的独立预测因素,阴离子间隙≥28者无良好恢复。甲醇组有3/55(5%)进展为神经学标准死亡。

要点

  • 甲醇中毒占ICU中毒性酒精中毒的53%(55/104),死亡、持续认知障碍或视力丧失复合终点达24%(13/55),高于乙二醇的3%(1/36)和异丙醇的0%(0/13)(p=0.006)。
  • 甲醇中毒患者中,阴离子间隙升高和GCS降低是不良结局的独立预测因素;就诊时阴离子间隙≥28者无良好恢复。
  • 神经影像异常在甲醇组为9/24(38%),乙二醇组为5/20(25%),异丙醇组为0/10(p=0.07);基底节在甲醇和乙二醇中毒中均常受累,但明显皮层下受累和弥散受限仅见于甲醇中毒。
  • 甲醇中毒组有3/55(5%)进展为神经学标准死亡,其他中毒性酒精组无此结局。
  • 作者强调阴离子间隙增宽独立预测不良结局,提示早期识别和治疗的重要性。

适用人群与场景

  • 2007至2019年加拿大阿尔伯塔省ICU收治的危重中毒性酒精中毒患者,共104例,其中甲醇55例(53%)、乙二醇36例(35%)、异丙醇13例(13%)。

红旗征与不能漏的情况

  • 甲醇中毒患者出现阴离子间隙升高和GCS降低提示不良结局风险,阴离子间隙≥28者无良好恢复。
  • 甲醇中毒可导致死亡、持续认知障碍或视力丧失,复合终点发生率为24%(13/55)。
  • 甲醇中毒组有5%(3/55)进展为神经学标准死亡。

研究设计与关键结果

  • 研究类型:多中心人群回顾性队列研究;样本量104例;人群:加拿大阿尔伯塔省ICU收治的中毒性酒精中毒危重患者;主要结局:神经影像异常在甲醇组9/24(38%)、乙二醇组5/20(25%)、异丙醇组0/10(p=0.07);死亡、持续认知障碍或视力丧失复合终点在甲醇组13例(24%)、乙二醇组1例(3%)、异丙醇组0例(p=0.006);甲醇组3/55(5%)进展为神经学标准死亡,其他组无。
  • 甲醇中毒患者中,阴离子间隙升高和GCS降低是不良结局的独立预测因素;阴离子间隙≥28者无良好恢复。

证据类型、等级与局限

  • 证据类型:多中心人群回顾性队列研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为阴离子间隙增宽独立预测不良结局,强调早期识别和治疗的重要性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Toxic alcohol poisoning is regularly encountered in emergency departments and intensive care units (ICUs). Most patients present with an altered level of consciousness, but the subsequent course and spectrum of neurologic complications and outcomes is highly variable.

METHODS: We performed a population-based, multicenter retrospective cohort study of critically ill patients with toxic alcohol poisoning admitted to ICUs in Alberta, Canada, between 2007 and 2019 to describe neurologic sequelae, including seizures, coma, neuroimaging abnormalities, persistent cognitive or visual impairment, and mortality. Multivariate analysis was performed to identify predictors of poor outcome.

RESULTS: We identified 104 patients, including 55 (53%) with methanol ingestion, 36 (35%) with ethylene glycol ingestion, and 13 (13%) with isopropanol ingestion. In patients who underwent neuroimaging, abnormalities were detected in 9 of 24 (38%) with methanol toxicity, 5 of 20 (25%) with ethylene glycol toxicity, and 0 of 10 with isopropanol toxicity (p = 0.07). Basal ganglia were commonly involved with both methanol and ethylene glycol poisoning, but prominent subcortical involvement and restricted diffusion were observed only with methanol poisoning. The composite of death, persistent cognitive impairment, or visual loss occurred in 13 (24%) patients with methanol poisoning, compared with one (3%) with ethylene glycol poisoning and none with isopropanol poisoning (p = 0.006). Among patients with methanol toxicity, greater elevation of the anion gap and lower Glasgow Coma Scale score were independent predictors of poor outcome. No patient with an anion gap ≥ 28 at presentation had a favorable recovery. Progression to death by neurologic criteria occurred in 3 of 55 (5%) patients with methanol poisoning and in none with other toxic alcohols.

CONCLUSIONS: Methanol overdose is the most common form of toxic alcohol poisoning to result in ICU admission. Poor neurologic outcomes may occur especially with methanol poisoning, with more than one in five patients dying or having persistent cognitive or visual impairment. A wide anion gap independently predicts poor outcome, emphasizing the importance of expeditious recognition and treatment.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. AlSamh DA, Kramer AH. Neurologic Complications in Critically Ill Patients with Toxic Alcohol Poisoning: A Multicenter Population-Based Cohort Study. Neurocrit Care. 2023. PMID: 37697128. doi:10.1007/s12028-023-01821-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。